India’s CDMO Sector Poised for a Massive $8 Billion Opportunity
With an estimated $8 billion market potential in the coming years, India is strategically positioned to enhance its global presence in the CDMO (Contract Development and Manufacturing Organization) space. However, to capitalize on this growth, significant investments in infrastructure, skilled workforce, and regulatory compliance will be essential.
In this special edition of Market Master, Madhu Kela, Founder of MK Ventures, engages in a discussion with industry stalwarts—Satyanarayana Chava, Founder and CEO of Laurus Labs, and Neeraj Sharma, MD and CEO of OneSource Specialty Pharma—on India’s evolving CDMO landscape.
Industry Insights: Transforming Strategies for Growth
Q: Over the past few years, Laurus Labs has successfully transitioned from being a major supplier of antiretroviral (ARV) drugs to establishing itself as a key player in the CDMO domain. Looking ahead, the company is venturing into biopharma and gene therapy. What drives your strategic approach, keeping you ahead in the industry?
Chava: The pharmaceutical sector is undergoing a major shift, and India is in a prime position to leverage this transformation. The market potential for Indian pharmaceutical companies in CRDMO (Contract Research, Development & Manufacturing Organization) is enormous. Your estimate suggests an $8 billion opportunity over the next few years.
To break it down, this opportunity can be categorized into two key segments:
-
Research & Development (R&D)
-
Development & Manufacturing
If we assume that half of the projected $8 billion opportunity is directed toward R&D and the other half toward development and manufacturing, then we are looking at a $4 billion segment for the latter. Capturing this market will require companies to invest heavily—around $3-4 billion in capital expenditures (capex)—not just in infrastructure but also in cutting-edge technology, skilled workforce recruitment, and advanced training programs.
Investments, Talent, and Future Prospects
The current scenario presents both financial strength and market demand. However, realizing this potential depends on securing the right talent and equipping them with the necessary training to meet industry standards. Companies that proactively invest in these areas will be well-positioned to achieve substantial growth and industry leadership in the CDMO space.
